جست‌وجوی استاد و پژوهشگر

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +۵ مورد دیگر

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.

Tianxi Caiمشاهده پروفایل

استاد

• Biomedical Informatics
• Biostatistics
• Machine Learning
• +۷ مورد دیگر

Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.

Vishal Ahujaمشاهده پروفایل

دانشیار

• Healthcare Operations
• Operations Management
• Service Operations
• +۷ مورد دیگر

Vishal Ahuja is an Associate Professor and Corrigan Research Professor at Southern Methodist University's Cox School of Business, with adjunct faculty status at University of Texas Southwestern Medical Center. He focuses on decision analytic tools for healthcare improvement through operations management. PhD, University of Chicago Booth School of Business MBA, University of Chicago Booth School of Business His research interests span healthcare operations, service optimization, and AI applications in clinical decision-making. He collaborates with the Department of Veterans Affairs, Parkland Hospital, and pediatric institutions to address care quality and delivery efficiency. Recent publications emphasize predictive modeling for chronic disease management, adaptive clinical trial design, and regulatory healthcare policy. Awards include the Dlin/Fischer Clinical Research Award (2021), INFORMS Pierskalla Award (2012), and 2025 AI75 recognition for Dallas-Fort Worth AI leadership. D CEO Excellence in Healthcare Award - Outstanding Healthcare Innovator (2023) NSF Game Changer Academies for Advancing Research Innovation (2022) C. Jackson Grayson Faculty Innovation Award (2022-23) At SMU, he teaches graduate courses in operations, supply chain, and service management, integrating corporate sector experience from chemical and consumer goods industries. His work has been cited by the FDA in safety labeling changes workshops.

Angela Pitenisمشاهده پروفایل

دانشیار

• Biomaterials
• Polymer Science
• Biomedical Engineering
• +۳ مورد دیگر

Angela Pitenis is an Associate Professor in the Department of Materials at the University of California, Santa Barbara (UCSB), within the College of Engineering. Her research focuses on interfacial phenomena in soft materials, particularly friction, adhesion, wear, and deformation of complex surfaces ranging from living cells to polymer nanocomposites. She employs advanced experimental techniques such as microscopy, spectroscopy, and interferometry to study these interfaces under extreme conditions and within buried environments. Her work has direct applications in healthcare, energy sustainability, and engineering design. Prof. Pitenis holds a Ph.D., M.Sc., and B.S. in Mechanical Engineering from the University of Florida. Her research group investigates biomaterials, hydrogel lubrication, and bioinspired materials, with recent studies addressing implant-associated inflammation, tumor cell dynamics in 3D microgels, and pH-responsive hydrogel friction. She is affiliated with the Materials Research Lab at UCSB and contributes to interdisciplinary projects at the intersection of materials science and biology. Notable research trends in her work include the development of biocompatible lubricious surfaces, understanding friction-induced biological responses, and designing smart materials with tunable mechanical properties. Her studies on photoresponsive hydrogels and superlubricious materials highlight innovations in responsive and adaptive material systems. Pitenis emphasizes in situ experimental methods and has pioneered techniques for analyzing dynamically evolving material interfaces. Her research also extends to marine biomaterials, such as the mechanical resilience of sessile tunicates, and explores applications in medical implants, bioreactors, and energy systems. While specific awards are not listed here, her contributions reflect a commitment to advancing soft matter tribology and biomaterials science.

Ying Geمشاهده پروفایل

استاد

• Biological Mass Spectrometry
• Proteomics
• Metabolomics
• +۷ مورد دیگر

Ying Ge is a Professor at the University of Wisconsin–Madison, jointly appointed in the Department of Cell and Regenerative Biology and the Department of Chemistry. Her research integrates chemistry, biology, and medicine, focusing on advanced mass spectrometry-based proteomic and metabolomic technologies to address cardiovascular diseases. Education: B.S., Peking University (1997) Ph.D., Cornell University (2002) Ying Ge's work centers on developing ultra high-resolution mass spectrometry platforms for top-down proteomics and metabolomics, applied to systems biology studies of heart failure and regenerative medicine. Key projects include myofilament protein modification mapping, stem cell therapy evaluation, and biomarker discovery for cardiac conditions. The 15 most recent articles highlight her lab's methodological innovations (e.g., photocleavable surfactants, native mass spectrometry) and biological discoveries in AMPK structural heterogeneity, RBM20-mediated cardiotoxicity, and sarcomere-metabolism cross-talk during regeneration. These publications span proteomics, metabolomics, structural biology, and clinical applications.

Ben Seiyon Leeمشاهده پروفایل

استادیار

• Computational Statistics
• Spatiotemporal Modeling
• Climate Change Impact Analysis
• +۳ مورد دیگر

Ben Seiyon Lee is an Assistant Professor in the Department of Statistics at George Mason University's College of Science. His work bridges computational statistics, climate modeling, and environmental risk assessment. Education: PhD in Statistics, Pennsylvania State University (2020) Lee specializes in computational methods for high-dimensional spatiotemporal data and uncertainty quantification in climate models. His research explores climate change impacts on extreme hydrological events, wildfire emissions, and medical decision-making. Recent publications focus on Bayesian spatiotemporal frameworks for extreme precipitation analysis, zero-inflated spatial models, and multisector uncertainty quantification. His work addresses challenges in flood risk assessment, agricultural yield projections, and healthcare compliance metrics.

Chris B. Schafferمشاهده پروفایل

استاد

• Biomedical Imaging and Instrumentation
• Bioengineering
• Neuroscience
• +۳ مورد دیگر

Chris B. Schaffer is a Professor in the Meinig School of Biomedical Engineering at Cornell University, specializing in developing advanced optical techniques to study neurovascular dynamics in neurological diseases. His lab focuses on Alzheimer’s disease mechanisms, leveraging multiphoton microscopy and in vivo imaging to explore capillary stalling, cerebral blood flow deficits, and their cognitive impacts. He holds a Ph.D. in Physics from Harvard University and postdoctoral training in neuroscience at UC San Diego. Research interests include biomedical imaging instrumentation, neurodegenerative disease modeling, and science education innovation. Awards include AAAS Fellowship (2021), AIMBE Fellowship (2019), and multiple teaching accolades. His work bridges engineering and medicine, with contributions to spinal cord injury studies, epilepsy, and vascular contributions to dementia (VCID). Notable discoveries include identifying neutrophil-induced capillary stalls as a key Alzheimer’s disease mechanism and demonstrating cerebral blood flow improvements can restore memory in mouse models. His lab also develops educational tools emphasizing science as a discovery process, used in K-12 and university settings.

Thanh Nho Doمشاهده پروفایل

مدرس ارشد

• Biomedical Engineering
• Surgical Robotics
• Soft Robotics
• +۵ مورد دیگر

Dr. Thanh Nho Do is a Scientia Senior Lecturer at the Graduate School of Biomedical Engineering (GSBmE), UNSW Sydney, and Director of the UNSW Medical Robotics Lab. He holds a PhD in Mechanical Engineering (Surgical Robotics) from Nanyang Technological University (NTU), Singapore, and a B.Eng. in Manufacturing Engineering from Ho Chi Minh City University of Technology, Vietnam. His research focuses on soft robotics, wearable technologies, and biomedical devices, including flexible surgical systems, soft actuators, and haptic interfaces. Education PhD in Mechanical Engineering (Surgical Robotics), NTU Singapore, 2015 B.Eng. in Manufacturing Engineering, Ho Chi Minh City University of Technology, Vietnam Research Interests Soft robotics for medical applications (e.g., NOTES systems, wearable haptics) Functional materials for biomedical devices Cardiovascular engineering and assistive devices Advanced control algorithms for medical robotics Key Contributions His work spans bioprinting, motor-free robotic systems, and soft wearable technologies. Recent studies include self-deploying cardiac compression devices and bioinspired artificial muscles. Awards 2025: CINSW Career Development Fellow 2024: NSW Young Tall Poppy Science Award 2023: Best Poster Awards at EMBC and ICRA Grants & Funding Includes NHMRC Ideas Grant (Lead CI), Cancer Institute NSW Fellowship, and UNSW Scientia Grant. Active projects address cardiovascular interventions and wearable robotics. Labs & Teams Leads the UNSW Medical Robotics Lab, collaborating on devices like soft robotic catheters and textile-driven exosuits.

Steff Lewisمشاهده پروفایل

استاد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Steff Lewis is a Professor of Medical Statistics at the University of Edinburgh , affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine . She leads the statistics group at the Edinburgh Clinical Trials Unit and holds roles in the Deanery of Molecular, Genetic and Population Health Sciences . Her expertise spans meta-analysis, randomized trial design, and clinical trial governance, with involvement in Cochrane Collaboration and UK Clinical Research Collaboration initiatives. Education: MSc and PhD in Medical Statistics. Research Interests: Focuses on methodological advancements in clinical trial reporting (e.g., CONSORT and SPIRIT guidelines), cardiovascular outcomes (e.g., SCOT-HEART trial), stroke prevention (ASPIRING trial), and ethical data management. She actively contributes to international standards for trial protocols, anonymization practices, and statistical validation. Recent Contributions: Over 200 peer-reviewed articles and 37 ongoing projects, including leadership in trials assessing antiplatelet therapies, Paget’s disease interventions, and pediatric asthma treatments. Collaborates globally on guidelines for randomized trials and data-sharing protocols. Grants & Teams: Principal or co-investigator on projects funded by NIHR, BHF, and ESRC, including trials on iron therapy in critical care (INTACT-2) and cannabinoid treatments for endometriosis pain (ENDO-CAN). Leads multidisciplinary teams integrating statistical rigor with clinical innovation. Labs/Teams: Embedded within the Edinburgh Clinical Trials Unit and the Centre for Population Health Sciences , fostering collaborative research across molecular, genetic, and public health domains.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

Su Ryon Shinمشاهده پروفایل

استادیار

• Bioengineering
• Tissue Engineering
• 3D Bioprinting
• +۷ مورد دیگر

Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.

• Exercise Physiology
• Cardiovascular Health
• Exercise as Medicine
• +۳ مورد دیگر

Ulrik Wisløff is a Professor and Head of the Cardiac Exercise Research Group (CERG) at the Norwegian University of Science and Technology (NTNU), Department of Circulation and Medical Imaging. He also holds an Honorary Professorship at the University of Queensland, Australia, and serves as Head of Physical Performance at Rosenborg FC. His research focuses on exercise physiology, translating experimental findings into clinical applications, and developing health technologies like the PAI (Personal Activity Intelligence) metric. Wisløff leads CERG, a 55-member group renowned for groundbreaking studies on exercise in cardiovascular health, aging, and disease prevention. He has authored over 340 peer-reviewed papers, with 127,000+ citations, and been recognized as one of the world's top-cited exercise scientists. Key achievements include the Fitness Calculator (used by 80.5 million people) and PAI, a free app with 70 million users worldwide. Current projects include NorEx (9,700 patients with myocardial infarction) and ExPlas (Alzheimer’s cognitive function trials). Wisløff has mentored 22 postdocs and 38 PhD students, advancing the next generation of researchers. His leadership extends to innovative ventures like the 'My Medical Digital Twin' project, spun into Mia Health Ltd. Scientific contributions span exercise physiology, cardiovascular risk prediction, and high-intensity training efficacy. Awards include Norway’s highest honor in heart research (2020). Research spans molecules-to-society translational medicine, emphasizing global health impact through physical activity advocacy.

Xuan Liمشاهده پروفایل

پژوهشگر ارشد

• Cardiovascular Medicine
• Microtubule Cell Biology
• Inflammatory Diseases
• +۳ مورد دیگر

Dr. Xuan Li is a British Heart Foundation (BHF) Senior Basic Science Research Fellow and Principal Investigator in Cardiovascular Health at the Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge. Her research focuses on microtubule dysfunction in inflammatory cardiovascular diseases, particularly investigating how microtubule regulation impacts inflammasome activation and cardiomyocyte contractility in heart failure and atherosclerosis. Her academic journey includes medical training in China, a CRUK-funded PhD in biochemistry at the University of Birmingham, postdoctoral research in microtubule cell biology as an MRC Career Development Fellow at the MRC-LMB Cambridge, and specialized cardiovascular medicine training at the University of Cambridge. She established her independent research group at Cambridge, pioneering multidisciplinary approaches to study microtubule function in cardiovascular cells. Dr. Li's research program centers on the role of microtubule-regulating kinases (particularly MARK4) in cardiovascular pathologies. Her group employs advanced methodologies including cardiovascular disease models (atherosclerosis, myocardial infarction, cardiomyopathy), primary cell culture of cardiomyocytes and immune cells, single-cell physiology using IonOptix systems, and cutting-edge microscopy techniques. Key discoveries include the identification of MARK4 as a critical regulator of inflammasome activation in atherosclerosis and microtubule detyrosination in ischemic heart failure. Her publication record demonstrates consistent focus on microtubule-cytoskeleton interactions in cardiovascular inflammation, with recent high-impact papers in Nature, Nature Communications, and Circulation Research revealing novel therapeutic targets for heart disease treatment through microtubule modulation. Scientific recognition includes: British Heart Foundation Senior Basic Science Research Fellowship MRC Career Development Fellowship Cancer Research UK PhD Studentship Dr. Li's group currently pursues four major research thrusts: elucidating microtubule dysfunction mechanisms in cardiovascular disease development, dissecting inflammation-microtubule interplay in pathogenesis, establishing human cardiomyocyte culture systems for microtubule studies, and translating basic findings into diagnostic and therapeutic applications for cardiovascular diseases. Her work bridges fundamental cell biology with clinical cardiology to develop innovative treatments targeting the microtubule cytoskeleton.

• Cardiothoracic Surgery
• Heart Valve Repair and Replacement
• Cardiac Imaging
• +۳ مورد دیگر

DE BONIS MICHELE is a Professor at San Raffaele Vita-Salute University , where he serves as the Director of the Cardiothoracic Surgery School. He is also the Chief of the Advanced and Research Cardiothoracic Surgery Unit at Ospedale San Raffaele , actively contributing to clinical and academic advancements in cardiovascular surgery since 2017. Research Interests : His work focuses on complex cardiac surgical techniques, including mitral and tricuspid valve repair, transcatheter interventions, and management of complications like pseudoaneurysms and thrombotic events. His recent publications highlight innovations in cardioplegia delivery, CT imaging for endocarditis, and outcomes of surgical and transcatheter approaches. Scientific Awards and Leadership : He has received notable awards such as the Premio "Eccellenze Lucane" (2018), Premio Nazionale Ciociaria (2005), and Premio di Medicina "Prof. Potito Petrone" (1995). He has held key roles in international societies, including President of the European Society of Cardiology's Cardiovascular Surgery Working Group (2014-2016) and Scientific Director of ESC/EACTS guidelines task forces. Teaching and Editorial Contributions : He supervises internships in surgery and cardiovascular diseases for the 6-year Master's Degree in Medicine and Surgery. He also serves as Editor-in-Chief and editorial board member for the International Journal of Cardiology .

Pierre Jaïsمشاهده پروفایل

استاد

• Cardiac Arrhythmias
• Atrial Fibrillation
• Catheter Ablation
• +۶ مورد دیگر

Prof. Pierre Jaïs serves as University Professor in Cardiology and Cardiac Electrophysiology at the University of Bordeaux and Head of the Electrophysiology Unit at Bordeaux University Hospital. He concurrently leads the Electrophysiology and Heart Modeling Institute (LIRYC) as CEO since 2021, driving innovation in cardiac rhythm disorder treatments through multidisciplinary research. His research revolutionized cardiac electrophysiology by identifying pulmonary veins as primary sources of atrial fibrillation, establishing pulmonary vein isolation as the global treatment standard. Current work focuses on pulsed field ablation—a non-thermal technique with potential to replace conventional ablation—and developing advanced imaging for precise arrhythmia targeting, reflecting his commitment to translating scientific discovery into clinical solutions. Analysis of recent publications (2017-2021) reveals dominant trends in pulsed field ablation optimization, comparative ablation techniques, and AI integration in cardiovascular imaging. These works consistently address atrial fibrillation treatment efficacy, safety profiles, and technological innovation, positioning him at the forefront of electrophysiology advancement. His distinguished contributions are recognized through prestigious awards including: 2019: Eli S. Gang Most Innovative Abstract Award (Heart Rhythm Society) 2018: Eric N. Prystowsky Lectureship Award 2012: Academy of Medicine Membership (Paris) 2009: Circulation Best Paper Award Multiple National Academy of Medicine honors Prof. Jaïs actively mentors electrophysiology trainees and secures substantial research funding, notably leading an EU-funded randomized trial comparing pulsed field versus thermal ablation. His LIRYC institute integrates cardiology, engineering, and computational expertise to accelerate therapeutic innovation. The LIRYC institute operates as a collaborative hub where clinicians, biomedical engineers, and data scientists develop next-generation electrophysiology tools. Current projects include real-time arrhythmia mapping systems, tissue-selective ablation protocols, and AI-driven predictive models for treatment personalization, fostering seamless translation from bench to bedside.